High Tower Advisors, LLC Amarin Corp Plcuk Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, High Tower Advisors, LLC holds 21,041 shares of AMRN stock, worth $10,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,041
Previous 121,391
82.67%
Holding current value
$10,941
Previous $83,000
84.34%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AMRN
# of Institutions
176Shares Held
65.1MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$12.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$6.46 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.72 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.32 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.3 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $210M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...